_id
69105d75ccc777a4e85d58c0
Ticker
DTCFF
Name
Defence Therapeutics Inc
Exchange
OTCQB
Address
7171 Rue Frederick-Banting, Montreal, QC, Canada, H4S1Z9
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://defencetherapeutics.com
Description
Defence Therapeutics Inc. develops a biological drug enhancer platform that improves the efficacy and safety of a multitude of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The company focuses on the research, development, and advancement of products using its Accum technology, including antibody drug conjugates targeting various cancers; the anti-cancer AccuTOX program, which has completed preclinical studies for solid T-cell lymphoma, breast cancer, and melanoma; the ARM-X vaccine program, a mesenchymal stem cell-based vaccine targeting cancer; and mRNA vaccination program. The company also offers Dendritic Cell (DC) cancer vaccines using Accum; a protein-based vaccine formulation against COVID and infectious diseases; and a cervical cancer vaccine. The company was formerly known as Accum Therapeutics Inc. and changed its name to Defence Therapeutics Inc. in March 2020. The company was incorporated in 2017 and is headquartered in Montreal, Canada.
Last Close
0.5287
Volume
200
Current Price
0.5133
Change
-0.0174
Last Updated
2026-01-02T12:52:03.740Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
30514866
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.969
Sentiment Sources
1
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
606581
Operating Income
-606581
Interest Expense
11920
Pretax Income
-634405
Net Income
-702996
Eps
-0.01284588847914596
Dividends Per Share
-
Shares Outstanding
54725370
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-15904
Cash
2320984
Short Term Investments
-
Receivables
221822
Inventories
-
Total Current Assets
2575979
Property Plant Equipment
192531
Total Assets
2768511
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
4175873
Equity
-1407362
Bs_currency_symbol
CAD
Depreciation
16240
Change In Working Capital
-221517
Cash From Operations
-720657
Capital Expenditures
21114
Cash From Investing
-
Cash From Financing
1824831
Net Change In Cash
1088557
Cf_currency_symbol
CAD
PE
-
PB
-19.95970647281936
ROE
49.9513273770359
ROA
-25.392566617940115
FCF
-741771
Fcf Percent
-
Piotroski FScore
0
Health Score
38
Deep Value Investing Score
1
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
5
Net Net Investing Score
0.5
Quality Investing Score
3
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
606581
Quarters > 0 > income Statement > operating Income
-606581
Quarters > 0 > income Statement > interest Expense
11920
Quarters > 0 > income Statement > pretax Income
-634405
Quarters > 0 > income Statement > net Income
-702996
Quarters > 0 > income Statement > eps
-0.01284588847914596
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
54725370
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-15904
Quarters > 0 > income Statement > currency_symbol
CAD
Quarters > 0 > balance Sheet > cash
2320984
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
221822
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
2575979
Quarters > 0 > balance Sheet > property Plant Equipment
192531
Quarters > 0 > balance Sheet > total Assets
2768511
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
4175873
Quarters > 0 > balance Sheet > equity
-1407362
Quarters > 0 > balance Sheet > currency_symbol
CAD
Quarters > 0 > cash Flow > net Income
-702996
Quarters > 0 > cash Flow > depreciation
16240
Quarters > 0 > cash Flow > change In Working Capital
-221517
Quarters > 0 > cash Flow > cash From Operations
-720657
Quarters > 0 > cash Flow > capital Expenditures
21114
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
1824831
Quarters > 0 > cash Flow > net Change In Cash
1088557
Quarters > 0 > cash Flow > currency_symbol
CAD
Quarters > 0 > ratios > PE
-0.01284588847914596
Quarters > 0 > ratios > PB
-19.95970647281936
Quarters > 0 > ratios > ROE
49.9513273770359
Quarters > 0 > ratios > ROA
-25.392566617940115
Quarters > 0 > ratios > FCF
-741771
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
-
Quarters > 1 > income Statement > operating Income
-
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-
Quarters > 1 > income Statement > net Income
-
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
CAD
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
-
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
-
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
-
Quarters > 1 > balance Sheet > equity
-
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
-
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-
Quarters > 1 > ratios > ROA
-
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
45
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
1028141
Quarters > 2 > income Statement > operating Income
-1028141
Quarters > 2 > income Statement > interest Expense
83370
Quarters > 2 > income Statement > pretax Income
-951888
Quarters > 2 > income Statement > net Income
-951888
Quarters > 2 > income Statement > eps
-0.017393907067234083
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
54725370
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
159623
Quarters > 2 > income Statement > currency_symbol
CAD
Quarters > 2 > balance Sheet > cash
2079660
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
87789
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
2171716
Quarters > 2 > balance Sheet > property Plant Equipment
191868
Quarters > 2 > balance Sheet > total Assets
2363585
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2583308
Quarters > 2 > balance Sheet > equity
-219723
Quarters > 2 > balance Sheet > currency_symbol
CAD
Quarters > 2 > cash Flow > net Income
-951888
Quarters > 2 > cash Flow > depreciation
17710
Quarters > 2 > cash Flow > change In Working Capital
-1411232
Quarters > 2 > cash Flow > cash From Operations
-1995920
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
3945060
Quarters > 2 > cash Flow > net Change In Cash
1949139
Quarters > 2 > cash Flow > currency_symbol
CAD
Quarters > 2 > ratios > PE
-0.017393907067234083
Quarters > 2 > ratios > PB
-127.84520701519641
Quarters > 2 > ratios > ROE
433.22182930325914
Quarters > 2 > ratios > ROA
-40.27305977995291
Quarters > 2 > ratios > FCF
-1995920
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
627497
Quarters > 3 > income Statement > operating Income
-627497
Quarters > 3 > income Statement > interest Expense
109434
Quarters > 3 > income Statement > pretax Income
-804837
Quarters > 3 > income Statement > net Income
-804837
Quarters > 3 > income Statement > eps
-0.016872762202892765
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
47700370
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-67906
Quarters > 3 > income Statement > currency_symbol
CAD
Quarters > 3 > balance Sheet > cash
130521
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
45887
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
193449
Quarters > 3 > balance Sheet > property Plant Equipment
209578
Quarters > 3 > balance Sheet > total Assets
403028
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
3856865
Quarters > 3 > balance Sheet > equity
-3453837
Quarters > 3 > balance Sheet > currency_symbol
CAD
Quarters > 3 > cash Flow > net Income
-804837
Quarters > 3 > cash Flow > depreciation
17709
Quarters > 3 > cash Flow > change In Working Capital
-146287
Quarters > 3 > cash Flow > cash From Operations
-668375
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
649101
Quarters > 3 > cash Flow > net Change In Cash
-677
Quarters > 3 > cash Flow > currency_symbol
CAD
Quarters > 3 > ratios > PE
-0.016872762202892765
Quarters > 3 > ratios > PB
-7.08910117095856
Quarters > 3 > ratios > ROE
23.30269204945109
Quarters > 3 > ratios > ROA
-199.69753962503847
Quarters > 3 > ratios > FCF
-668375
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
39
Annuals > 0 > quarter
2025-06-30
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
-
Annuals > 0 > income Statement > operating Income
-
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-
Annuals > 0 > income Statement > net Income
-
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
CAD
Annuals > 0 > balance Sheet > cash
-
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
-
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
-
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
-
Annuals > 0 > balance Sheet > equity
-
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-
Annuals > 0 > cash Flow > capital Expenditures
-
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
-
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-
Annuals > 0 > ratios > ROA
-
Annuals > 0 > ratios > FCF
-
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
45
Annuals > 1 > quarter
2024-06-30
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
12821880
Annuals > 1 > income Statement > operating Income
-12821880
Annuals > 1 > income Statement > interest Expense
397854
Annuals > 1 > income Statement > pretax Income
-13193045
Annuals > 1 > income Statement > net Income
-13193045
Annuals > 1 > income Statement > eps
-0.2897235158132875
Annuals > 1 > income Statement > dividends Per Share
0
Annuals > 1 > income Statement > shares Outstanding
45536673
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
4803
Annuals > 1 > income Statement > currency_symbol
CAD
Annuals > 1 > balance Sheet > cash
56547
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
96523
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
214152
Annuals > 1 > balance Sheet > property Plant Equipment
263595
Annuals > 1 > balance Sheet > total Assets
477747
Annuals > 1 > balance Sheet > payables
-
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
4061975
Annuals > 1 > balance Sheet > equity
-3584228
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-13193045
Annuals > 1 > cash Flow > depreciation
90924
Annuals > 1 > cash Flow > change In Working Capital
2579229
Annuals > 1 > cash Flow > cash From Operations
-4288380
Annuals > 1 > cash Flow > capital Expenditures
203239
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
1755235
Annuals > 1 > cash Flow > net Change In Cash
-2736384
Annuals > 1 > cash Flow > currency_symbol
CAD
Annuals > 1 > ratios > PE
-0.2897235158132875
Annuals > 1 > ratios > PB
-6.716994291406685
Annuals > 1 > ratios > ROE
368.08609831740614
Annuals > 1 > ratios > ROA
-2761.512892807281
Annuals > 1 > ratios > FCF
-4491619
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2023-06-30
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
6545360
Annuals > 2 > income Statement > operating Income
-6545360
Annuals > 2 > income Statement > interest Expense
262933
Annuals > 2 > income Statement > pretax Income
-6867783
Annuals > 2 > income Statement > net Income
-6762783
Annuals > 2 > income Statement > eps
-0.15446959542011618
Annuals > 2 > income Statement > dividends Per Share
0
Annuals > 2 > income Statement > shares Outstanding
43780674
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-66299
Annuals > 2 > income Statement > currency_symbol
CAD
Annuals > 2 > balance Sheet > cash
2792931
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
149605
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
3434711
Annuals > 2 > balance Sheet > property Plant Equipment
59222
Annuals > 2 > balance Sheet > total Assets
3532709
Annuals > 2 > balance Sheet > payables
-
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
1746069
Annuals > 2 > balance Sheet > total Liabilities
1966542
Annuals > 2 > balance Sheet > equity
1566167
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-6762783
Annuals > 2 > cash Flow > depreciation
13823
Annuals > 2 > cash Flow > change In Working Capital
661664
Annuals > 2 > cash Flow > cash From Operations
-6518437
Annuals > 2 > cash Flow > capital Expenditures
65803
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
3894362
Annuals > 2 > cash Flow > net Change In Cash
-2684845
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.15446959542011618
Annuals > 2 > ratios > PB
14.77929387083242
Annuals > 2 > ratios > ROE
-431.80471814308436
Annuals > 2 > ratios > ROA
-191.43334477875194
Annuals > 2 > ratios > FCF
-6584240
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
16
Annuals > 3 > quarter
2022-06-30
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
7320131
Annuals > 3 > income Statement > operating Income
-7296264
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-7343998
Annuals > 3 > income Statement > net Income
-7343998
Annuals > 3 > income Statement > eps
-0.20356271999449627
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
36077323
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-23867
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
506696
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
27756
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
673648
Annuals > 3 > balance Sheet > property Plant Equipment
0
Annuals > 3 > balance Sheet > total Assets
719666
Annuals > 3 > balance Sheet > payables
979724
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1107224
Annuals > 3 > balance Sheet > equity
-387558
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-7343998
Annuals > 3 > cash Flow > depreciation
0
Annuals > 3 > cash Flow > change In Working Capital
928333
Annuals > 3 > cash Flow > cash From Operations
-6044395
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
1098185
Annuals > 3 > cash Flow > net Change In Cash
-4946210
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.20356271999449627
Annuals > 3 > ratios > PB
-49.216067453387616
Annuals > 3 > ratios > ROE
1894.9416603450325
Annuals > 3 > ratios > ROA
-1020.4731083585998
Annuals > 3 > ratios > FCF
-6044395
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.01284588847914596
Valuation > metrics > PB
-19.95970647281936
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
49.9513273770359
Profitability > metrics > ROA
-27.290439867716316
Profitability > final Score
55
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-50.887667785234896
Risk > final Score
-174
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
50
Prev Profitabilities > 1
55
Prev Profitabilities > 2
55
Prev Risks > 0
50
Prev Risks > 1
-19
Prev Risks > 2
7
Prev Liquidities > 0
50
Prev Liquidities > 1
50
Prev Liquidities > 2
50
Updated At
2026-01-20T21:44:04.484Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.0093
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-06-30
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.0153
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-03-31
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0135
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2024-12-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.0125
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-09-30
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.0098
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-06-30
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.0216
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-03-31
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0221
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2023-12-31
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.1385
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-09-30
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.0373
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-06-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0298
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-03-31
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0256
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2022-12-31
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.0388
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-09-30
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.0353
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-06-30
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.0466
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-06-21
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.037
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2021-12-31
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.0428
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-26
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.0342
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-09-30
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.034
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-06-30
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.0419
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.0419
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-31
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.0192
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.0192
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-12-31
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.0144
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.0144
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-09-30
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.0016
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.0016
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-06-30
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.1004
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.1004
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-31
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.4316
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.4316
Earnings History > 23 > surprise Percent
-
Defence Therapeutics Inc. develops a biological drug enhancer platform that improves the efficacy and safety of a multitude of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The company focuses on the research, development, and advancement of products using its Accum technology, including antibody drug conjugates targeting various cancers; the anti-cancer AccuTOX program, which has completed preclinical studies for solid T-cell lymphoma, breast cancer, and melanoma; the ARM-X vaccine program, a mesenchymal stem cell-based vaccine targeting cancer; and mRNA vaccination program. The company also offers Dendritic Cell (DC) cancer vaccines using Accum; a protein-based vaccine formulation against COVID and infectious diseases; and a cervical cancer vaccine. The company was formerly known as Accum Therapeutics Inc. and changed its name to Defence Therapeutics Inc. in March 2020. The company was incorporated in 2017 and is headquartered in Montreal, Canada.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AInside-the-cell cancer drugs: Defence Therapeutics builds around Accum Stock Titan
Read more →(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Defence Therapeutics Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.0093
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.